البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
OSELTAMIVIR AS PHOSPHATE
ROCHE PHARMACEUTICALS (ISRAEL) LTD
J05AH02
CAPSULES
OSELTAMIVIR AS PHOSPHATE 45 MG
PER OS
Required
HOFFMANN LA ROCHE LTD, SWITZERLAND
OSELTAMIVIR
Treatment of influenza : Treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days. Prophylaxis of influenza : Post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older.
2014-09-22
BODY WEIGHT RECOMMENDED DOSAGE FOR 10 DAYS OF TREATMENT* WHICH CAPSULE SHOULD BE TAKEN? Less or equal to 15 kg 30 mg once daily 1 capsule of 30 mg once daily More than 15 kg up to 23 kg 45 mg once daily 1 capsule of 45 mg once daily More than 23 kg up to 40 kg 60 mg once daily 2 capsules of 30 mg once daily More than 40 kg 75 mg once daily 1 capsule of 75 mg or 1 capsule of 30 mg + 1 capsule of 45 mg once daily * In the event of an outbreak of influenza in the community, preventive treatment with TAMIFLU can be taken for a period of up to 6 weeks. Consult your attending doctor regarding for how long the medicine should be taken. ADULTS (FROM 13 YEARS OF AGE AND ABOVE): ∙ TREATMENT Start treatment immediately upon the first appearance of influenza symptoms (up to 48 hours). The recommended dosage is 75 mg TAMIFLU twice daily for 5 days. ∙ PREVENTION Start preventive treatment immediately after exposure to the disease and/or as soon as you suspect you have been infected. The recommended dosage is 75 mg TAMIFLU once daily. The doctor will recommend the length of time that the medicine has to be taken for. Generally, when taking preventive treatment after close contact with a person with influenza, the recommended length of time will be at least 10 days. In the event of an outbreak of influenza in the community, preventive treatment with TAMIFLU can be taken for up to 6 weeks . In patients suffering from kidney insufficiency (Creatinine clearance 10-60 mL/min), the dosages have to be adjusted. During treatment with TAMIFLU, if there is no improvement in the influenza symptoms or there is a deterioration or development of new symptoms, consult the attending doctor. Do not exceed the recommended dosage. Swallow the medicine with water. In special circumstances and only with the instruction of your doctor or pharmacist: The capsule can be opened and its entire contents swallowed in the following way: ∙ Take the required dose of TAMIFLU capsules: 30, 45, 60 or 75 mg. ∙ Open the capsule carefully and pour the comp اقرأ الوثيقة كاملة
טמרופ ןולע הז עבקנ ע " י דרשמ תואירבה ונכותו קדבנ רשואו לע ודי ב טסוגוא 2015 1 TAMIFLU ® r Oseltamivir CAPSULES 1 INDICATIONS AND USAGE TREATMENT OF INFLUENZA : The treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older (30mg and 45 mg) who have been symptomatic for no more than 2 days. PROPHYLAXIS OF INFLUENZA : - Post exposure prevention in adults and children 1 year of age or older following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. - The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains, and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older. TAMIFLU CAPSULES 75 MG is indicated for patients who weight > 40 k body weight. LIMITATIONS OF USE The following points should be considered before initiating treatment or prophylaxis with TAMIFLU: - Efficacy of TAMIFLU in patients who begin treatment after 48 hours of symptoms has not been established. - TAMIFLU is not a substitute for early influenza vaccination on an annual basis as recommended by the MOH (Ministry of Health). - There is no evidence for efficacy of TAMIFLU in any illness caused by agents other than influenza viruses types A and B. - Influenza viruses change over time. Emergence of resistance mutations could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use TAMIFLU. 2 DOSAGE AND ADMINISTRATION 2.1 DOSING FOR TREATMENT AND PROPHYLAXIS OF INFLUENZA Treatment should begin within 2 d اقرأ الوثيقة كاملة